Role of fibronectin-stimulated tumor cell migration in glioma invasion in vivo: Clinical significance of fibronectin and fibronectin receptor expressed in human glioma tissues

Clinical and Experimental Metastasis

Volumn 16, Issue 8, 1998, Pages 729-741

  Ohnishi, Takanori ^a   Hiraga, Shoju ^a   Izumoto, Shuichi ^a   Matsumura, Hirotaka ^a   Kanemura, Yonehiro ^a   Arita, Norio ^a   Hayakawa, Toru ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Cell migration; Fibronectin; Fibronectin receptor; Invasion; Malignant glioma

Indexed keywords

FIBRONECTIN; FIBRONECTIN RECEPTOR;

ARTICLE; ASTROCYTOMA; CANCER CELL CULTURE; CANCER INVASION; CELL MIGRATION; EPENDYMOMA; EXTRACELLULAR MATRIX; GLIOBLASTOMA; GLIOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN DETERMINATION; PROTEIN LOCALIZATION;

ASTROCYTOMA; CELL ADHESION; CELL MOVEMENT; EPENDYMOMA; FIBRONECTINS; GLIOBLASTOMA; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTEIN ISOFORMS; RECEPTORS, FIBRONECTIN; TUMOR CELLS, CULTURED;

EID: 0032414023     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006532812408     Document Type: Article

References (45)

1. 1. Liotta LA, Rao CN and Wewer UM, 1986, Biochemical interactions of tumor cells with the basement membrane. Ann Rev Biochem, 55, 1037-57.
2. 2. Mareel MM, 1980, Recent aspects of tumor invasiveness. In: Richter GW, Epstein MA, eds. International Review of Experimental Pathology. New York: Academic Press, 65-129.
3. 3. Chiquet-Ehrismann R, Mackie EJ, Pearson CA, Pearson CA and Sakakura T, 1986, Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell, 47, 131-9.
4. 4. Reichardt LF and Tomaselli KJ, 1991, Extracellular matrix molecules and thier receptors: functions in neural development. Ann Rev Neurosci, 14, 531-70.
5. 5. Sanes JR, 1989, Extracellular matrix molecules that influence neural developement. Ann Rev Neurosci, 12, 491-516.
6. 6. Paetau A, Mellstrom K, Vaheri A and Haltia M, 1980, Distribution of a major connective tissue protein, fibronectin, in normal and neoplastic human nervous tissue. Acta Neuropathol, 51, 47-51.
7. 7. Rutka JT, Apodaca G, Stern R and Rosenblum M, 1988, The extracellular matrix of the central and peripheral nervous systems: structure and function. J Neurosurg, 69, 155-70.
8. 8. Carbonetto S, 1984, The extracellular matrix of the nervous system. Trends Neurosci, 7, 382-7.
9. 9. Venstrom KA and Reichard LF, 1993, Extracellular matrix 2: role of extracellular matrix molecules and their receptors in the nervous system. FASEB, 7, 996-1003.
10. 10. Schachner M, Schoonmaker G and Hynes RO, 1978, Cellular and subcellular localization of LETS protein in the nervous system. Brain Res, 158, 149-58.
11. 11. Chintala SK, Sawaya R, Gokaslan ZL, et al. 1996, Immunohistochemical localization of extracellular matrix proteins in human glioma, both in vivo and in vitro. Cancer Lett, 101, 107-14.
12. 12. Bronner-Fraser M, 1986, An antibody to a receptor for fibronectin and laminin perturbs cranial neural crest development. Dev Biol, 117, 528-36.
13. 13. Ohnishi T, Arita N, Hayakawa T, et al. 1990, Motility factor produced by malignant glioma cells: role in tumor invasion. J Neurosurg, 73, 881-8.
14. 14. Terranova VP, Rohrbach DH and Martin GR, 1980, Role of laminin in the attachment of PAM212 (epithelial) cells to basement membrane collagen. Cell, 22, 719-26.
15. 15. Giese A, Rief HD, Loo A and Berens ME, 1994, Determinants of human astrocytoma migration. Cancer Res, 54, 3897-904.
16. 16. Tysnes BB, Larsen LF, Ness GO, et al. 1996, Stimulation of glioma-cell migration by laminin and inhibition by anti-α3 and anti-β1 integrin antibodies. Int J Cancer, 67, 777-84.
17. 17. Ohnishi T, Arita N, Hiraga S, et al. 1997, Fibronectin-mediated cell migration promotes glioma cell invasion through chemokinetic activity. Clin Exp Metastasis, 15, 538-46.
18. 18. Kleihues P, Burger PC and Scheithauer BW, eds, 1993, Histolgical Typing of Tumours of the Central Nervous System, 2nd ed. Berlin: Springer-Verlag.
19. 19. Hsu SM, Raine L and Fanger H, 1981, Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem, 29, 577-80.
20. 20. Cavenee WK, Dryja TP, Philips RA, et al. 1984, Isolation and regional localization of DNA segments revealing polymorphic loci from human chromosome 13. Am J Hum Genet, 36, 10-24.
21. 21. Freiberg AP and Vogelstein B, 1984, A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem, 137, 266-7.
22. 22. Gutman A and Kornblihtt AR, 1987, Identification of a third region of cell-specific alternative splicing in human fibronectin mRNA. Proc Natl Acad Sci USA, 84, 7179-82.
23. 23. Kornblihtt AR, Vibe-Pedersen K and Baralle FE, 1984, Human fibronectin: cell specific alternative mRNA splicing generates polypeptide chains differing in the number of internal repeats. Nucleic Acids Res, 12, 5853-68.
24. 24. Schwarzbauer JE, Tamkun JW, Lemischka IR and Hynes RO, 1983, Three different fibronectin tnRNAs arise by alternative splicing within the coding region. Cell, 35, 421-31.
25. 25. Zardi L, Carnemolla B, Siri A, et al. 1987, Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previusly unobserved exon. EMBO J, 6, 2337-42.
26. 26. Oyama F, Hirohashi S, Shimosato Y, et al. 1990, Oncodevelopmental regulation of the alternative splicing of fibronectin pre-messenger RNA in human lung tissues. Cancer Res, 50, 1075-8.
27. 27. Oyama F, Hirohashi S, Sakamoto M, et al. 1993, Coorinate oncodevelopmental modulation of alternative splicing of fibronectin pre-messenger RNA at ED-A, ED-B, and CS1 regions in human liver tumors. Cancer Res, 33, 2005-11.
28. 28. Friedlander DR, Zagzag D, Shiff B, et al. 1996, Migration of brain tumor cells on extracellular matrix proteins in vitro correlates with tumor type and grade and involves αv and β1 integrins. Cancer Res, 56, 1939-47.
29. 29. Xia P and Culp LA, 1994, Adhesion activity in fibronectin's alternatively spliced domain Eda (EIIIA) and its neighboring type III repeats: oncogene-dependent regulation. Exp Cell Res, 213, 253-65.
30. 30. Chen W and Culp LA, 1996, Adhesion mediated by fibronectin's alternatively spliced Edb (EIIIB) and its neighboring type III repeats. Exp Cell Res, 223, 9-19.
31. 31. Hynes RO, 1987, Integrins: a family of cell surface receptors. Cell, 48, 549-54.
32. 32. Hynes RO, 1992, Integrins: versatility, modulation, and signaling in cell adhesion. Cell, 69, 11-25.
33. 33. Dedhar S and Saulnier R, 1990, Alterations in integrin receptor expression on chemically transformed human cells: specific enhancement of laminin and collagen receptor complexes. J Cell Biol, 110, 481-9.
34. 34. Plantefaber LC and Hynes RO, 1989, Changes in integrin receptors on oncogenically transformed cells. Cell, 56, 281-90.
35. 35. Singer II, Scott S, Kawka DW, et al 1988, Cell surface distribution of fibronectin and vitronectin receptors depends on substrate composition and extracellular matrix accumulation. J Cell Biol, 106, 2171-82.
36. 36. Wayner EA, Garcia-Pardo A, Humphries MJ, et al. 1989, Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J Cell Biol, 109, 1321-30.
37. 37. Zhang Y, Saison M, Spaepen M, et al. 1988, Mapping of human fibronectin receptor β subunit gene to chromosome 10. Somatic Cell Mol Genet, 14, 99-104.
38. 38. Goodfellow PJ, Nevanlinna HA, Gorman P, et al. 1989, Assignment of the gene encoding the beta subunit of the human fibronectin receptor (beta-FNR) to chromosome 10 p11.2. Ann Hum Genet, 53, 15-22.
39. 39. Wu J, Giuffra LA, Goodfellow PJ, et al. 1989, The β subunit locus of the human fibronectin receptor: DNA restriction fragment length polymorphism and linkage mapping studies. Hum Genet, 83, 383-90.
40. 14C-alpha-amino-isobutyric acid in rat C6 glioma. J Neuro-Oncol, 8, 197-204.
41. 41. Yamada K, Ushio Y, Hayakawa T, et al. 1983, Effects of methyl-predonosolone on peritumoral brain edema. A quantitative autoradiographic study. J Neurosurg, 59, 612-9.
42. 42. Enam SA, Rosenblum ML and Edvardsen K, 1998, Role of extracellular matrix in tumor invasion: migration of glioma cells along fibronectin-positive mesenchymal cell processes. Neurosurg, 42, 599-608.
43. 43. Nakagawa T, Kubota T, Kabuto M, et al. 1994, Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg, 81, 69-77.
44. 44. Yamamoto M, Mohanam S, Sawaya R, et al. 1996, Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res, 56, 384-92.
45. 45. Ohnishi T, Matsumura H, Izumoto S, et al. 1998, A novel model of glioma cell invasion using organotypic brain slice culture. Cancer Res 58, 2935-40.